ATLN
NASDAQ
US
Atlantic International Corp. - Common Stock
$3,51
▲ +$0,00
(+0,00%)
Vol. 27K
5
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$77.8M
ROE
-479,4%
Margine
-22,7%
D/E
506,25
Beta
1,19
52W
$1–$8
Consenso Wall Street
7 analisti · Apr 20263
Acquisto forte
3
Compra
1
Mantieni
0
Vendi
0
Vendita forte
85,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
LAB
Standard BioTools Inc
$492.2M
OABI
OmniAb Inc
$266.3M
QTRX
Quanterix Corp
$297.1M
TKNO
Alpha Teknova Inc
$203.4M
CDXS
Codexis Inc
$147.2M
QSI
Quantum-Si Inc
$237.0M
LFCR
Lifecore Biomedical Inc
$306.5M
SEER
Seer Inc
$102.1M
Utili
Tasso di battuta: 0,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Set 2025 | $-0,18 | $-0,20 | $-0,02 |
| Dic 2022 | $-3,26 | $-4,00 | $-0,74 |
| Dic 2021 | $-1,63 | $-4,68 | $-3,05 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Ricavi | $107.8M | $129.5M | $102.8M | $102.9M | $110.1M |
| Utile netto | -$7.0M | -$68.7M | -$10.7M | -$10.7M | -$10.8M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -476.2% | -476.2% | -476.2% | -479.4% | -479.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -10.4% | -31.8% | -21.9% | -21.9% | -21.9% | -22.7% |
| Gross Margin | 11.1% | 10.8% | 10.8% | 10.8% | 10.8% | 10.8% |
| D/E Ratio | — | 498.08 | 498.08 | 498.08 | 506.25 | 506.25 |
| Current Ratio | 1.31 | 0.62 | 1.31 | 1.31 | 1.31 | 1.23 |
Rapporti chiave
ROA (TTM)
-90,5%
P/S (TTM)
0,17
EPS (TTM)
$-2,00
Crescita ricavi 3A
+1182,1%
52W High
$7,97
52W Low
$1,16
$1,16
Intervallo 52 settimane
$7,97
Salute finanziaria
Flusso di cassa libero
-$1.3M
Debito netto
$78.5M
Liquidità
$83K
Debito totale
$78.6M
Aggiornato al Set 30, 2025
Як ATLN виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Micro-cap Life Sciences Tools & Services (All) · 44 компаній
Оцінка ATLN vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
sotto
peer
(32,5)
vs Peer
vs Settore
Sottovalutato
P/S
0,2
▼
95%
sotto
peer
(3,7)
vs Peer
vs Settore
Sottovalutato
P/B
—
▼
0%
sotto
peer
(2,0)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,5%)
vs Peer
vs Settore
Rendimento basso
Прибутковість ATLN vs аналоги Life Sciences Tools & Services
ROE
-479,4%
▼
1842%
sotto
peer
(-24,7%)
vs Peer
vs Settore
Debole
Net margin
-22,7%
▲
19%
sopra
peer
(-27,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
10,9%
▼
78%
sotto
peer
(48,2%)
vs Peer
vs Settore
Debole
ROA
-90,5%
▼
521%
sotto
peer
(-14,6%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя ATLN vs аналоги Life Sciences Tools & Services
D/E ratio
506,3
▲
2086%
sopra
peer
(23,2)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,2
▼
63%
sotto
peer
(3,3)
vs Peer
vs Settore
Liquidità bassa
Beta
1,2
▼
14%
sotto
peer
(1,4)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів ATLN
ATLN
Mediana peer
Industria
ATLN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ATLN vs аналоги: ключові метрики
Ultime notizie
Nessuna notizia correlata ancora